Cleveland Clinic pursues RVAD
This article was originally published in The Gray Sheet
Executive Summary
Clinic's biomedical engineering department will develop a right-ventricle version of Arrow International's CorAide left-ventricular assist device, also created at the Cleveland Clinic. RVAD development will be funded by a $6.95 mil., five-year contract from the National Heart, Lung & Blood Institute. "If the CorAide LVAD can be modified and used as an RVAD, the resulting CorAide biventricular assist device would be an ideal system for patients who need support for their LVAD to function properly," explained project leader Kiyotaka Fukamachi, MD/PhD. The CorAide LVAD currently is in a European pilot study (1"The Gray Sheet" April 19, 2004, p. 23)...